IMS Consulting & Expert Services | Litigation Insights is proud to support the American Conference Institute’s 26th Annual Conference on Drug and Medical Device Litigation. The event will be held on December 7-8, 2021, at the Marriott Marquis in New York, NY. Attendees of the annual conference will be participating in two days of panel discussions featuring 60+ leading trial attorneys and defense counsel. Each year 400+ professionals attend to network and discuss actionable strategies to surmount new litigation challenges.
On Wednesday, December 8 at 11:45 AM ET, IMS | Litigation Insights Jury Consulting Advisor Christina Marinakis will be a panelist for Assessing How the COVID-19 Pandemic is Impacting Juror Mindsets, Perceptions, and Verdicts: What is the Data Showing? Discussion topics will include:
- Will post-COVID goodwill towards pharmaceutical and medical device companies play out at trial?
- Are we seeing discrepancies between juror attitudes towards drug companies vs. device companies?
- How to relate juror reluctance to serve during the pandemic to how their perspectives would be while actually sitting on the jury
- Are we seeing any correlation between vaccine hesitancy and juror perceptions of drug companies?
- What does the data say about vaccine-hesitant jurors and their view of pharma companies: What can be gleaned from “Have you been vaccinated?” on a juror questionnaire?
The American Conference Institute is one of three companies associated with the C5 Group. This organization hosts conferences and summits that provide the business intelligence which decision-makers need to make timely decisions in today’s marketplace.
Learn more about jury consulting services with IMS here.